Recent advances in genetic systems in obligate intracellular human-pathogenic bacteria

The ability to genetically manipulate a pathogen is fundamental to discovering factors governing host-pathogen interactions at the molecular level and is critical for devising treatment and prevention strategies. While the genetic "toolbox" for many important bacterial pathogens is extensi...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cellular and infection microbiology Vol. 13; p. 1202245
Main Authors Fisher, Derek J, Beare, Paul A
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 19.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The ability to genetically manipulate a pathogen is fundamental to discovering factors governing host-pathogen interactions at the molecular level and is critical for devising treatment and prevention strategies. While the genetic "toolbox" for many important bacterial pathogens is extensive, approaches for modifying obligate intracellular bacterial pathogens were classically limited due in part to the uniqueness of their obligatory lifestyles. Many researchers have confronted these challenges over the past two and a half decades leading to the development of multiple approaches to construct plasmid-bearing recombinant strains and chromosomal gene inactivation and deletion mutants, along with gene-silencing methods enabling the study of essential genes. This review will highlight seminal genetic achievements and recent developments (past 5 years) for spp., spp., spp., and including progress being made for the still intractable . Alongside commentary of the strengths and weaknesses of the various approaches, future research directions will be discussed to include methods for . that should have utility in the other obligate intracellular bacteria. Collectively, the future appears bright for unraveling the molecular pathogenic mechanisms of these significant pathogens.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-2
Edited by: Rey Carabeo, University of Nebraska Medical Center, United States
Reviewed by: Hector Alex Saka, Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI) (CONICET), Argentina; Ulrike G. Munderloh, University of Minnesota Twin Cities, United States
ISSN:2235-2988
2235-2988
DOI:10.3389/fcimb.2023.1202245